Перейти к содержимому

Ozempic vs. Mounjaro: GLP-1 Weight Loss Explained | Dr. Friedman

Dr. Friedman's Endocrinology Clinic

0:00 / 0:00

Ozempic vs. Mounjaro: GLP-1 Weight Loss Explained | Dr. Friedman

54 просмотра · 6 дн. назад
Dr. Friedman's Endocrinology Clinic
1,38 тыс. подписчиков
54 просмотра · 6 дн. назад
*Ozempic, Wegovy, Mounjaro & Zepbound: Understanding GLP-1 Weight Loss Medications* How do GLP-1 medications work, and what should patients know about their benefits, side effects, dosing, and long-term use? In this presentation from the 2026 MAGIC Foundation Conference, endocrinologist Dr. Theodore C. Friedman explores the science behind GLP-1 medications, including semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). Dr. Friedman discusses how these medications affect appetite, insulin secretion, blood sugar, and weight management, particularly in patients with hormonal conditions such as Cushing's disease, hypothyroidism, growth hormone deficiency, and PCOS/PMOS. *Topics covered:* How GLP-1 and GIP medications work Semaglutide versus tirzepatide Weight loss results and individualized treatment Common side effects and strategies for managing them Muscle loss, protein intake, and healthy lifestyle habits Insurance coverage and medication costs Compounded GLP-1 medications and microdosing Long-term treatment and weight maintenance Potential benefits beyond weight loss Emerging medications, including retatrutide Patient questions and answers Dr. Friedman also discusses his approach to personalized endocrinology care, emphasizing nutrition, exercise, sleep, and the importance of addressing underlying hormonal disorders. *About Dr. Theodore C. Friedman* Dr. Friedman is an endocrinologist and Professor of Medicine at Charles R. Drew University, affiliated with UCLA. His clinical work focuses on complex endocrine disorders and individualized hormone treatment. Learn more about Dr. Friedman, his educational resources, and appointment options: https://www.goodhormonehealth.com/ *Medical disclaimer:* This presentation is for educational purposes only and reflects the speaker's discussion at the time of recording. GLP-1 medications have important contraindications and potential adverse effects. Compounded GLP-1 medications are not FDA-approved, and their availability and legal requirements are subject to regulation. Consult a qualified healthcare professional before starting, stopping, or changing any medication. #GLP1 #Ozempic #Mounjaro #Wegovy #Zepbound